María Cecilia Rodríguez-Galán

Suggest Changes
Learn More
IL-12 is an excellent candidate for the treatment of cancer due to its ability to drive strong antitumor responses. Recombinant IL-12 protein is currently used in cancer patients; however, systemic(More)